166 related articles for article (PubMed ID: 12201348)
21. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
[TBL] [Abstract][Full Text] [Related]
22. Long-term treatment of retinitis pigmentosa with acetazolamide. A pilot study.
Orzalesi N; Pierrottet C; Porta A; Aschero M
Graefes Arch Clin Exp Ophthalmol; 1993 May; 231(5):254-6. PubMed ID: 8319913
[TBL] [Abstract][Full Text] [Related]
23. Acetazolamide in dominant cystoid macular dystrophy. A pilot study.
Pinckers A; Cruysberg JR; Kremer H; Aandekerk AL
Ophthalmic Paediatr Genet; 1993 Jun; 14(2):95-9. PubMed ID: 8233360
[TBL] [Abstract][Full Text] [Related]
24. Comparison of two individualized treatment regimens with ranibizumab for diabetic macular edema.
Ebneter A; Waldmeier D; Zysset-Burri DC; Wolf S; Zinkernagel MS
Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):549-555. PubMed ID: 27714513
[TBL] [Abstract][Full Text] [Related]
25. Cystoid macular edema associated with cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
Silverstein BE; Smith JH; Sykes SO; Jones MR; Schwartz D; Cunningham ET
Am J Ophthalmol; 1998 Mar; 125(3):411-5. PubMed ID: 9512171
[TBL] [Abstract][Full Text] [Related]
26. Intravitreal dexamethasone for diabetic macular edema: a pilot study.
Chan CK; Mohamed S; Lee VY; Lai TY; Shanmugam MP; Lam DS
Ophthalmic Surg Lasers Imaging; 2010; 41(1):26-30. PubMed ID: 20128566
[TBL] [Abstract][Full Text] [Related]
27. Rebound of cystoid macular edema with continued use of acetazolamide in patients with retinitis pigmentosa.
Apushkin MA; Fishman GA; Grover S; Janowicz MJ
Retina; 2007 Oct; 27(8):1112-8. PubMed ID: 18040255
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and prognostic factors of response to carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa.
Liew G; Moore AT; Webster AR; Michaelides M
Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1531-6. PubMed ID: 25670491
[TBL] [Abstract][Full Text] [Related]
29. [Intravitreal triamcinolone combined with grid laser photocoagulation for patients with cystoid macular edema and advanced diabetic retinopathy: pilot study].
Arévalo JF; Fernández CF; Mendoza AJ; García RA; Arévalo FA
Arch Soc Esp Oftalmol; 2013 Oct; 88(10):373-9. PubMed ID: 24060300
[TBL] [Abstract][Full Text] [Related]
30. Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa.
Fishman GA; Gilbert LD; Fiscella RG; Kimura AE; Jampol LM
Arch Ophthalmol; 1989 Oct; 107(10):1445-52. PubMed ID: 2803090
[TBL] [Abstract][Full Text] [Related]
31. Treatment of cystoid macular edema with oral acetazolamide in a patient with best vitelliform macular dystrophy.
Hori K; Ishida S; Inoue M; Shinoda K; Kawashima S; Kitamura S; Oguchi Y
Retina; 2004 Jun; 24(3):481-2. PubMed ID: 15187682
[No Abstract] [Full Text] [Related]
32. Decreased macular thickness in nonproliferative macular telangiectasia type 2 with oral carbonic anhydrase inhibitors.
Chen JJ; Sohn EH; Folk JC; Mahajan VB; Kay CN; Boldt HC; Russell SR
Retina; 2014 Jul; 34(7):1400-6. PubMed ID: 24451922
[TBL] [Abstract][Full Text] [Related]
33. Diabetic macular edema: correlation between microperimetry and optical coherence tomography findings.
Vujosevic S; Midena E; Pilotto E; Radin PP; Chiesa L; Cavarzeran F
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3044-51. PubMed ID: 16799051
[TBL] [Abstract][Full Text] [Related]
34. PROSPECTIVE RANDOMIZED SUBJECT-MASKED STUDY OF INTRAVITREAL BEVACIZUMAB MONOTHERAPY VERSUS DEXAMETHASONE IMPLANT MONOTHERAPY IN THE TREATMENT OF PERSISTENT DIABETIC MACULAR EDEMA.
Shah SU; Harless A; Bleau L; Maturi RK
Retina; 2016 Oct; 36(10):1986-96. PubMed ID: 27124881
[TBL] [Abstract][Full Text] [Related]
35. Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment.
Karst SG; Lammer J; Mitsch C; Schober M; Mehta J; Scholda C; Kundi M; Kriechbaum K; Schmidt-Erfurth U
Graefes Arch Clin Exp Ophthalmol; 2018 Jan; 256(1):49-58. PubMed ID: 29080915
[TBL] [Abstract][Full Text] [Related]
36. intravitreal tumor necrosis factor inhibitors in the treatment of refractory diabetic macular edema: a pilot study from the Pan-American Collaborative Retina Study Group.
Wu L; Hernandez-Bogantes E; Roca JA; Arevalo JF; Barraza K; Lasave AF
Retina; 2011 Feb; 31(2):298-303. PubMed ID: 21099452
[TBL] [Abstract][Full Text] [Related]
37. Optical coherence tomographic assessment of diabetic macular edema: comparison with fluorescein angiographic and clinical findings.
Ozdek SC; Erdinç MA; Gürelik G; Aydin B; Bahçeci U; Hasanreisoğlu B
Ophthalmologica; 2005; 219(2):86-92. PubMed ID: 15802932
[TBL] [Abstract][Full Text] [Related]
38. Intravitreal cortisone injection for refractory diffuse diabetic macular edema.
Er H; Yilmaz H
Ophthalmologica; 2005; 219(6):394-400. PubMed ID: 16286802
[TBL] [Abstract][Full Text] [Related]
39. A direct correlation of the resolution of pseudophakic cystoid macular edema with acetazolamide therapy.
Tripathi RC; Fekrat S; Tripathi BJ; Ernest JT
Ann Ophthalmol; 1991 Apr; 23(4):127-9. PubMed ID: 2064253
[TBL] [Abstract][Full Text] [Related]
40. A Nine-Year Follow-Up of Macular Complications in Retinitis Pigmentosa and Diabetes Mellitus.
Mucciolo DP; Sodi A; Murro V; Virgili G; Rizzo S
Ophthalmic Surg Lasers Imaging Retina; 2017 Apr; 48(4):340-344. PubMed ID: 28419400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
